Sarah Jessica Parker cuts ties with EpiPen after price hike

Under fire, the CEO of Mylan, the maker of the Epipen, says the company is taking immediate steps to lower the cost to some patients.

When asked why the company chose discount counts instead of lowering the price, Bresch said the flawed health care system would prevent the real savings from reaching those who need EpiPen.

However, Mylan bosses have upset the actress by raising the cost of the prescription allergy medication to over $500 (£379), after price hikes in 2014 and 2015.

Mylan is boosting programs to help patients pay for its EpiPen emergency allergy treatment after heated criticism about an average cost that has soared over the past decade.

She went on further dodge the question by pointing out ways that her company has worked for years to be sure that schools have EpiPens on hand. A complex and opaque system may encourage high prices for drugs, but also doesn’t force the likes of Mylan to jack them up.

EpiPens accounted for 87 percent of all epinephrine prescriptions filled by pharmacies past year.

They’re forced to buy in packs of two, and the latest calculations show the cost of EpiPens has jumped 575 percent in ten years. Thursday, it upped that discount to $300, about a 50% discount off the list price.

Numerous members of Congress and other politicians this week have called for congressional hearings on Mylan’s pricing, an investigation by the Federal Trade Commission and action by the Food and Drug Administration to increase competition by speeding up approvals of any rival products.

On CNBC Thursday morning, Bresch said nobody is more frustrated than her.

“She has several, actually they’re environmental allergies”, Ford said. The syringes, prefilled with the hormone epinephrine, expire after a year.

Mylan just injected some adrenaline into the USA healthcare debate.

On Thursday, August 25, Parker announced on Instagram that she had ended her relationship with the pharmaceutical company due to the price hikes of EpiPen.

“I was dumbfounded and of course it’s a very serious issue”, said Dina Clifford. Customers of Express Scripts Holding Co., the nation’s largest pharmacy benefits manager, pay about $73.50 out of pocket for an EpiPen prescription, spokesman Brian Henry said. Sen.

Over that same period, the CEO of Mylan has watched her salary go up, from $2.4 million to almost $19 million.

Shares of Mylan closed down more than 5 percent at $43.15 on the Nasdaq.